Research Article

Investigation of antiviral activity of four microalgae and two cyanobacteria extracts on infectious bronchitis virus

Volume: 43 Number: 1 March 9, 2026
TR EN

Investigation of antiviral activity of four microalgae and two cyanobacteria extracts on infectious bronchitis virus

Abstract

Many studies indicate that microalgae and cyanobacteria, widely used in cosmetics, medicine, various industrial areas, and as food sources for humans and animals, have potential applications in alternative treatments. These species have high nutritional value due to their high protein, carbohydrate, and fatty acid content. Microalgae display diverse morphological and physiological features, and their biological properties vary according to the metabolites they produce. The therapeutic properties of microalgae have been investigated in numerous scientific studies. The literature reports that microalgae possess anticancer, cholesterol-lowering, anti-inflammatory, antioxidant, and antiviral activities, as well as the ability to stimulate the immune system. Interest in compounds with antiviral activity against SARS-CoV-2, which emerged in China and spread worldwide, is currently at its peak. The discovery and isolation of bioactive compounds with antiviral effects is of great importance. In this study, the antiviral effects of Arthrospira platensis, Prasinococcus sp., Nanofrustulum shiloi, Phaeodactylum tricornutum, Scenedesmus sp., and Pseudanabaena sp. were investigated. The antiviral effects of extracts from these microalgae/cyanobacteria species were assessed by in ovo experiments in the embryonated chicken egg system using the Infectious Bronchitis Virus (IBV) D274 strain, which agglutinates erythrocytes. Among the microalgae/cyanobacteria species, Pseudanabaena sp., which exhibits the lowest hemagglutination activity (log2HA=4 at 5 mg/kg and log2HA=5 at 10 mg/kg), shows the strongest and most potent antiviral activity and is more effective at 5 mg/kg than at 10 mg/kg.

Keywords

Supporting Institution

Ege University Scientific Research Projects Coordination

Project Number

FM-GAP-2022-23516

Ethical Statement

The studies were carried out with the approval of the Ege University ethics committee (Approval No: 2020- 051)

References

  1. Afify, A.E.M.M., El Baroty, G.S., El Baz, F.K., Abd El Baky, H.H., & Murad, S.A. (2018). Scenedesmus obliquus: Antioxidant and antiviral activity of proteins hydrolyzed by three enzymes. Journal of Genetic Engineering and Biotechnology, 16(2), 399 408. https://doi.org/10.1016/j.jgeb.2018.01.002
  2. Alsakini, K.A.M.H., Çöven, F.O., & Nalbantsoy, A. (2024). Adjuvant effects of novel water/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice. Biologicals, 85, 101736. https://doi.org/10.1016/j.biologicals.2023.101736
  3. Ayehunie, S., Belay, A., Baba, T., & Ruprecht, R.M. (1998). Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(1), 7–12. https://doi.org/10.1097/00042560-199805010-00002
  4. Bavington, C.D., & Moss, C. (2013). Polysaccharides from Prasinococcales (WO Patent No. WO 2013167911 A1). World Intellectual Property Organization.
  5. Carbone, D.A., Pellone, P., Lubritto, C., & Ciniglia, C. (2021). Evaluation of microalgae antiviral activity and their bioactive compounds. Antibiotics, 10(7), 746. https://doi.org/ 0.3390/antibiotics10060746
  6. Cegłowska, M., Szubert, K., Grygier, B., Lenart, M., Plewka, J., Milewska, A., Lis, K., Szczepański, A., Chykunova, Y., Barreto-Duran, E., Pyrć, K., Kosakowska, A., & Mazur-Marzec, H. (2022). Pseudanabaena galeata CCNP1313 – Biological activity and peptides production. Toxins, 14(6), 330. https://doi.org/10.3390/toxins14050330
  7. Chaisuwan, W., Phimolsiripol, Y., Chaiyaso, T., Techapun, C., Leksawasdi, N., Jantanasakulwong, K., Rachtanapun, P., Wangtueai, S., Sommano, S.R., You, S., Regenstein, J.M., Barba, F.J., & Seesuriyachan, P. (2021). The antiviral activity of bacterial, fungal, and algal polysaccharides as bioactive ingredients: Potential uses for enhancing immune systems and preventing viruses. Frontiers in Nutrition, 8, 772033. https://doi.org/10.3389/fnut.2021.772033
  8. Çöven F.O., Gür, S., Uyar, E., Alsakini, K.A.M.H., Karabey, F., Çöven, F., Çalış, İ., & Nalbantsoy, A. (2024). Assessment of in-vitro cytotoxicity and in-ovo virucidal antiviral efficacy of various plant extracts and bioactive molecules. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 30(2), 171-178. https://doi.org/10.9775/kvfd.2023.30306 da Silva, M.B.F., Teixeira, C.M.L.L. (2024). Cyanobacterial and microalgae polymers: antiviral activity and applications. Brazilian Journal of Microbiology, 55, 3287–3301. https://doi.org/10.1007/s42770-024-01452-5

Details

Primary Language

English

Subjects

Ecology (Other) , Fisheries Technologies

Journal Section

Research Article

Publication Date

March 9, 2026

Submission Date

November 13, 2025

Acceptance Date

February 12, 2026

Published in Issue

Year 2026 Volume: 43 Number: 1

APA
Atak, E., Ak, B., Çöven, F. O., Nalbantsoy, A., Demirel, Z., & Conk Dalay, M. (2026). Investigation of antiviral activity of four microalgae and two cyanobacteria extracts on infectious bronchitis virus. Ege Journal of Fisheries and Aquatic Sciences, 43(1), 86-93. https://doi.org/10.12714/egejfas.43.1.10